v3.26.1
Equity Method Investments (Details) - USD ($)
2 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Feb. 26, 2025
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Mar. 31, 2025
Feb. 09, 2023
Equity Method Investment [Line Items]                  
Equity method investments, net           $ 10,636,544    
Purchased interests           20,666,667      
Cash   $ 39,221   $ 39,221   109,091 2,658,182    
Preferred stock, value          
Cost of investment                 $ 19,460,000
Amortization expense   563,000 1,126,000 2,158,167      
Loss from equity method investment       $ 392,677 392,677 (846,588)    
Distribution of earnings           1,745,000      
Intangible assets             8,725,712    
Goodwill   $ 12,808,197   $ 12,808,197   $ 12,808,197    
Customer Relationships [Member]                  
Equity Method Investment [Line Items]                  
Estimated useful life           15 years      
Series B Stated Value [Member]                  
Equity Method Investment [Line Items]                  
Equity method investment payable           $ 666,667      
Laboratory Services MSO [Member]                  
Equity Method Investment [Line Items]                  
Ownership percentage 40.00%         40.00%      
Cash           $ 9,000,000      
Amortization expense $ 111,156           666,932    
Impairment loss             259,579    
Loss from equity method investment 503,833           79,923    
Distribution of earnings 0           611,888    
Series B Preferred Stock [Member]                  
Equity Method Investment [Line Items]                  
Equity method investments, net $ 11,000,000                
Preferred stock, value           $ 11,000,000    
Issuance shares (in Shares)           0 11,000    
Conversion price per share (in Dollars per share)           $ 56.7      
Series B Convertible Preferred Stock [Member]                  
Equity Method Investment [Line Items]                  
Equity method investments, net               $ 11,029,221  
Preferred stock, value           $ 1,000      
Conversion price per share (in Dollars per share)           $ 56.7      
Aggregate of common stock (in Shares)           194,004      
Avalon Lab [Member]                  
Equity Method Investment [Line Items]                  
Total ownership percentage 40.00%                
Avalon Lab [Member] | Series B Preferred Stock [Member]                  
Equity Method Investment [Line Items]                  
Preferred stock, value           $ 11,000,000      
Issuance shares (in Shares)           11,000      
Avalon Lab [Member] | Series B Stated Value [Member]                  
Equity Method Investment [Line Items]                  
Preferred stock, value           $ 1,000      
Unrelated Company [Member]                  
Equity Method Investment [Line Items]                  
Total ownership percentage 60.00%